CLINICAL_TRIALS
trial_result
· 2014-06-11
Clinical Trial Update: Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma [Phase 2]
Summary
Phase 2 study evaluating 4 weeks of inhaled BI 1744 CL in asthma patients reported efficacy and safety outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-11